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Abstract
Background: The prevalence of pediatric hormonal disorders and hormonally-sensitive cancers are rising.
Chemicals including bisphenol A (BPA), phthalates, parabens, 4-nonylphenol (4NP) and triclosan have been linked
to disruption of endocrine pathways and altered hormonal status in both animal and human studies. Additionally,
changes in estrogen metabolism have been associated with pediatric endocrine disorders and linked to estrogen-
dependent cancers. The main objective of the study was to measure the presence of these environmental
chemicals in prepubescent children and assess the relationship between chemical metabolites and estrogen
metabolism.
Methods: 50 subjects (25 male, 25 female) were recruited from the principal investigator’s existing patient
population at his pediatric primary care office. The first 5 boys and 5 girls in each age group (4 through 8 years old
inclusive) who presented for annual examinations were included, as long as they were Tanner Stage I (prepubertal)
on physical exam, without diagnosis of hormonally-related condition and/or cancer and able to give a urine
sample. Urine samples were collected in glass containers for analysis of chemical and estrogen metabolites. Study
kits and lab analysis were provided by Genova Diagnostics (Duluth, GA).
Summary statistics for the concentrations of each chemical metabolite as well as estrogen metabolites were
computed (minimum, maximum, median and inter-quartile range) for males only, for females only and for all
subjects. Comparisons between groups (e.g. males v. females) were assessed using the nonparametric Wilcoxon
test, since the data was skewed. The correlation between concentrations of chemical metabolites and estrogen
metabolites in prepubescent children were examined by the Spearman’s correlation coefficient (ρ).
Results: 100 % of subjects had detectible levels of at least five chemicals in their urine, and 74 % had detectible
levels of eight or more chemicals. Of note, 100 % of subjects demonstrated presence of at least one chemical in
each class of BPA, phthalates, and parabens. 28 % of subjects had measurable levels of 4NP. No associations were
found between the urine levels of chemicals and estrogen metabolites.
Conclusions: Endocrine disrupting environmental chemicals were detected in all children in the study, with
measurable levels of 4NP in nearly 1/3 of subjects. This is the first known published study of 4NP levels in American
children. No associations were found between the urine levels of chemicals tested and estrogen metabolites. The
presence of multiple chemicals in a majority of children’s urine coupled with increasing prevalence of pediatric
hormonal disorders warrants further research to elucidate potential causal mechanisms in pre- and post-pubertal
children.
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Background
In the United States, cancer is the leading cause of
disease-related death among children and adolescents
[1]. The incidence of pediatric cancers has increased at an
annual rate of 0.6 % since 1975 [2]. The largest contribu-
tor to this rise has been the germ cell, trophoblastic, and
other gonadal tumor category, specifically testicular and
ovarian germ cell tumors [2]. Additionally, studies have
concluded that the incidence of altered pubertal onset is
increasing, especially in girls [3]. Both developments have
been linked to environmental factors, including exposure
to endocrine disrupting chemicals [4–6]. Childhood
exposure to these chemicals is widespread [4]. Of greatest
concern are chemicals with potential for both endocrine
disruption and carcinogenesis, including bisphenol A
(BPA), phthalates, parabens, 4-nonylphenol (4NP) and
triclosan [5–7].
BPA is commonly found in polycarbonate plastic prod-
ucts including baby bottles, water bottles, food containers,
in the linings of metal food cans and in dental sealants
and composites [8]. BPA has been found in over 90 % of
the U.S. population age six and over, with highest concen-
trations in children ages 6–11 [8]. Triclosan is commonly
found in antibacterial hand soaps, toothpastes and house-
hold cleaning supplies [9]. Phthalate chemicals “soften”
plastics to make them pliable. They are also found in per-
sonal care products, food, plastic toys and household dust
[10]. Parabens are found in common personal care prod-
ucts including cosmetics and antiperspirants [10]. 4NP is
one of the most common alkylphenols (APs) in industry,
used in the production of cleaning products, plastics, rub-
ber and personal care products, including hair products
and spermicides [11]. APs are commonly used to make
alkylphenolethoxylates (APEs), which are widely used sur-
factants and detergents [12, 13]. Despite widespread use,
exposure data on 4NP is scarce. To our knowledge, there
is no published data on 4NP exposures in American chil-
dren [12, 14–20]. All of these five chemicals have been de-
tected in a majority of the U.S. population [10, 12, 21].
BPA, phthalates, triclosan, parabens and 4NP have
been linked to disruption of endocrine pathways and
altered hormonal status in both animal and human
studies. Two pediatric studies have linked phthalate ex-
posure to precocious puberty in girls [6, 13] while an-
other study found an association between urinary
concentrations of high-molecular weight phthalate me-
tabolites and later pubarche [22]. BPA, triclosan, 4NP
and parabens have also been associated with endocrine
disruption or hormonally derived cancers in vitro and in
animal models [7, 23–27]. Changes in estrogen metabol-
ism, specifically in the ratio of 16a-Hydroxyestrone
(16a-OHE1) to 2-Hydroxyestrone (2-OHE1) metabo-
lites, have been associated with hormone disruption and
linked to estrogen-dependent cancers [28, 29].
Given the widespread exposure of humans to these
chemicals and the concern about environmental factors
causing endocrine disruption and cancer in children, our
study team investigated whether the levels of urinary
chemical metabolites in children are correlated with
levels and ratios of urinary estrogen metabolites. Such
an association may increase the risk of these children to
develop endocrine disruption, altered pubertal onset,
and hormonally-associated cancers.
Methods
Potential subjects were recruited from the principal in-
vestigator’s existing patient population at his pediatric
primary care office, the Whole Child Center in Oradell,
NJ from December 2012 through April 2014. Patients
who come to the principal investigator’s office for a
scheduled checkup were evaluated for eligibility. Subject
selection was based on consecutive patients meeting the
study criteria. There were 5 boys and 5 girls in each age
group, 4–8 years inclusive in the study, meeting inclu-
sion criteria as Tanner Stage 1 (displaying no secondary
sexual characteristics on physical exam verified by PI),
toilet trained and able to provide a urine sample.
Subjects could have no diagnosed hormonally related
disorder or cancer and could not be taking any hormo-
nally active medication. At least one parent/guardian
needed to be able and willing to give written informed
consent.
Recruitment procedures & informed consent
Subjects were recruited by the PI (LR), who discussed
the study with parents of eligible children. As the
study’s PI, Dr. Rosen is familiar with the protocol and
has received documented education in the protection
of human research subjects.
To comply with best practices in ethical approval and
consent, this research study was conducted in accord-
ance with the Declaration of Helsinki and was approved
prior to the commencement by the HackensackUMC
Institutional Review Board (HIRB protocol number
Pro00003454). The protocol and de-identified clinical
dataset will be made available upon request to any
scientist wishing to use them for non-commercial
purposes.
After having all questions answered to their satisfac-
tion, parent(s)/guardian(s) who agreed to their child’s
participation in the study were asked to sign a current,
IRB approved informed consent document and HIPAA
authorization form. The signed consent document in-
cluded a statement informing parents/guardians that
their child’s identity will remain confidential if the re-
sults of the trial are published. Pediatric assent was not
obtained from subjects prior to participation.
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Lab analysis procedure
Study kits and lab analysis were provided by Genova
Diagnostics (Duluth, GA). Samples were collected at the
primary care office with the assistance of a parent/
guardian. The urine sample was collected directly into a
glass jar. Approximately 10 ml of urine was liquated
from the black-capped glass collection container into the
yellow-capped polypropylene plastic vial using the
enclosed polyethylene pipette. Room-temperature urine
was aliquot immediately into the vial upon the subject’s
parent or guardian giving the glass collection jar to the
research nurse. Both the black-capped collection con-
tainer and the yellow-capped plastic vial were placed in
a biohazard bag with a completed requisition form. Sam-
ples were refrigerated immediately after processing until
shipment. Samples were shipped overnight in the speci-
men collection kit box with the frozen ice packs
provided to Genova Diagnostics for analysis. The lab
used urinary creatinine as a control for concentration and
considered samples valid for analysis using creatinine.
Limits of detection for the chemicals tested are included
in Table 1. Our team confirmed that first morning urine
was not necessary for the variables being measured in this
study. The following analyses were performed on each
sample:
1. Bisphenol A Profile (analysis method: Gas
Chromatography/Mass Spectrometry) – Urine:
includes Bisphenol A (BPA), 4-Nonylphenol (4NP),
and Triclosan
2. Phthalates and Parabens (analysis method: Liquid
Chromatography Tandem Mass Spectrometry) –
Urine: includes metabolites of Di-2-ethylhexyl
phthalate (DEHP) which include Mono-(2-ethyl-
5-hydroxyhexyl) phthalate (MEHHP), Mono-2-
ethylhexyl phthalate (MEHP), Mono-(2-ethyl-5-
oxohexyl) phthalate (MEOHP), and Mono-ethyl
phthalate (MEtP) and Parabens (Butylparaben,
Ethylparaben, Methylparaben, and Propylparaben)
Estronex Estrogen Metabolites (analysis method:
Ultra Performance Liquid Chromatography with Tandem
Mass Spectrometry) – Urine: 2-Hydroxyestrone (2-OHE1),
2-Hydroxyestradiol (2-OHE2), 2-Hydroxyestrogens
(2-OHE1 + 2) = Sum of 2-Hydroxyestrone (2-OHE1) and
2-Hydroxyestradiol (2-OHE2), 2-Methoxyestrone (2-OMeE1),
4-Hydroxyestrone (4-OHE1), 4-Methoxyestrone (4-OMeE1),
and 16 alpha-hydroxyestrone (16a-OHE1).
Statistical considerations
A total of 50 children (25 male and 25 female) between
4 and 8 years inclusive were enrolled into the study, with
5 males and 5 females for each age. Additional subjects,
selected using the same recruitment procedures, were
needed to account for damaged specimen collection or
incomplete results due to insufficient urine collected
and/or inability of the lab to result all analytes in specific
cases. This resulted in a total of 68 subjects enrolled,
yielding 50 evaluable subjects. Descriptive statistics and
tests were conducted for each year, totaling 5 groups.
Results are reported by males only, females only and
both genders combined.
For exploratory purposes, summary statistics for the
concentrations of each chemical metabolite were com-
puted (minimum, maximum, median and inter-quartile
range) for males, for females and for all subjects. These
statistics were computed both including and excluding
subjects with chemicals below the limits of detection
(LOD). When computing summaries and tests with the
full data, half the values of the limit of detection were
used for these subjects. Table 1 shows these two sets of
summary statistics. The proportion of subjects with con-
centrations below the LOD was calculated for each
chemical metabolite. Similar summary statistics were
computed for the estrogen metabolites as well.
Comparisons between groups (e.g. males v. females) were
assessed using the nonparametric Wilcoxon test, since the
data was skewed. The correlation between concentrations
of chemical metabolites and estrogen metabolites in pre-
pubescent children were examined by the Spearman’s cor-
relation coefficient (ρ). We considered ρ values of 0.60-0.79
to indicate high correlation, values of 0.40-0.59 moderate,
and values of 0.20-0.39 weak or low correlations. In cases
where there are outliers, these were removed and the cor-
relation coefficient recomputed to assess the effect of these
outliers. All data analysis in this study was performed using
R and SAS 9.2 (SAS Institute Inc., Cary, NC). Note that we
do not formally account for multiple comparisons and re-
port only the unadjusted p values. The Bonferroni correc-
tion is a simple way to correct for multiple
comparisons (albeit conservatively). This can be done
by the reader by reducing his/her threshold for a sig-
nificant p value. For example, in this paper, we use a
p value of 0.1. With multiple testing this would re-
quire rejection at approximately 0.1/10 = 0.01 for the
roughly 10 environmental chemicals and 10 estrogen
variables considered in our study.
Results and discussion
100 % of subjects had detectible levels of at least five chemi-
cals in their urine, and 74% had detectible levels of eight or
more chemicals. Of note, 100% of subjects demonstrated
presence of at least one chemical in each class of BPA,
phthalates, and parabens. No significant differences were
found in mean values between males and females or be-
tween age groups for any of the chemicals (Table 1).
14 % of subjects had all ten chemicals present. Not-
ably, 28 % of subjects had measurable levels of 4NP.
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Table 1 Urinary Chemicals – including and excluding measurements below the limit of detection
A = all Includes subjects below limits of detection
(replaced with LOD/2)






F = females only
50 Subjects # below limit of detection % below limit of detection Min Median IQR Max Min Median IQR
BisphenolA 35 70 A = 0.05 A = 1.12 A = 2.83 A = 10.80 A = 0.17 A = 2.05 A = 2.2300 0.096
LOD = 0.101 ng/mL M = 0.05 M = 0.58 M = 1.78 M = 10.80 M = 0.40 M = 1.61 M = 2.715
F = 0.05 F = 1.64 F = 2.12 F = 8.63 F = 0.17 F = 2.35 F = 1.955
Triclosan LOD = 0.399 ng/mL 47 94 A = 0.20 A = 18.50 A = 112.75 A = 2207.00 A = 1.00 A = 21.00 A = 129.5000 0.32
M = 0.20 M = 22.00 M = 73.00 M = 2207.00 M = 1.00 M = 24.00 M = 83.000
F = 0.20 F = 14.00 F = 142.00 F = 707.00 F = 1.00 F = 14.00 F = 187.500
4-Nonylphenol 14 28 A = 0.11 A = 0.11 A = 0.13 A = 6.25 A = 0.21 A = 0.56 A = 1.5375 0.92
LOD = 0.225 ng/mL M = 0.11 M = 0.11 M = 0.10 M = 6.25 M = 0.21 M = 0.68 M = 1.885
F = 0.11 F = 0.11 F = 0.14 F = 4.12 F = 0.25 F = 0.37 F = 0.865
MEHHP 50 100 A = 7.00 A = 25.00 A = 23.50 A = 187.00 A = 7.00 A = 25.00 A = 23.5000 0.95
LOD = 1.022 g/L M = 8.00 M = 25.00 M = 15.00 M = 187.00 M = 8.00 M = 25.00 M = 15.000
F = 7.00 F = 22.00 F = 25.00 F = 104.00 F = 7.00 F = 22.00 F = 25.000
MEHP 50 100 A = 0.40 A = 3.90 A = 3.83 A = 24.70 A = 0.40 A = 3.90 A = 3.8250 0.56
LOD = 0.199 g/L M = 1.00 M = 3.80 M = 3.60 M = 24.70 M = 1.00 M = 3.80 M = 3.600
F = 0.40 F = 4.00 F = 4.00 F = 15.20 F = 0.40 F = 4.00 F = 4.000
MEOHP 49 98 A = 0.84 A = 13.00 A = 10.00 A = 76.00 A = 4.00 A = 13.00 A = 10.0000 0.63
LOD = 1.674 g/L M = 0.84 M = 13.00 M = 9.00 M = 76.00 M = 5.00 M = 13.50 M = 9.000
F = 4.00 F = 12.00 F = 13.00 F = 67.00 F = 4.00 F = 12.00 F = 13.000
MetP 50 100 A = 5.00 A = 20.50 A = 14.25 A = 358.00 A = 5.00 A = 20.50 A = 14.2500 0.28
LOD = 0.830 g/L M = 5.00 M = 18.00 M = 8.00 M = 358.00 M = 5.00 M = 18.00 M = 8.000
F = 5.00 F = 22.00 F = 14.00 F = 162.00 F = 5.00 F = 22.00 F = 14.000
Butylparaben 6 12 A = 0.17 A = 0.17 A = 0.00 A = 5.90 A = 0.60 A = 1.15 A = 1.9250 0.077
LOD = 0.332 g/L M = 0.17 M = 0.17 M = 0.00 M = 0.60 M = 0.60 M = 0.60 M = 0.000
F = 0.17 F = 0.17 F = 0.00 F = 5.90 F = 0.60 F = 1.40 F = 2.100
Ethylparaben 36 72 A = 0.15 A = 0.60 A = 1.05 A = 8.80 A = 0.30 A = 0.90 A = 0.8000 0.63
LOD = 0.298 g/L M = 0.15 M = 0.50 M = 0.95 M = 1.90 M = 0.30 M = 0.90 M = 0.775













Table 1 Urinary Chemicals – including and excluding measurements below the limit of detection (Continued)
Methylparaben 50 100 A = 1.00 A = 16.50 A = 24.50 A = 1000.00 A = 1.00 A = 16.50 A = 24.5000 0.50
LOD = 0.494 g/L M = 1.00 M = 9.00 M = 25.00 M = 1000.00 M = 1.00 M = 9.00 M = 25.000
F = 2.00 F = 19.00 F = 22.00 F = 267.00 F = 2.00 F = 19.00 F = 22.000
Propylparaben 15 30 A = 1.90 A = 1.90 A = 3.10 A = 124.00 A = 5.00 A = 8.00 A = 6.5000 0.95
LOD = 3.802 g/L M = 1.90 M = 1.90 M = 3.10 M = 124.00 M = 5.00 M = 9.00 M = 31.000
F = 1.90 F = 1.90 F = 3.10 F = 42.00 F = 5.00 F = 7.50 F = 6.000













Existing research on 4NP is very limited, with a range
of findings. While prior research has documented de-
tectible 4NP levels in adults [12, 16, 20], this is the first
known published study of 4NP exposure in American
children. Interestingly, prior research in a general Bel-
gian population of 131 subjects aged 1 to 75 (average
age of 29.6) did not find 4NP in detectible levels in the
urine samples analyzed [15]. Another study in 11 hu-
man tissue samples of patients aged between 9 and
62 years (average age of 34 years), found mostly un-
detectable levels of 4NP and concluded the chemical is
not of significant importance for human exposure [17].
However, a study measuring nonylphenol in Taiwanese
children aged 6.5–15.0 years found NP in 84 to 94 % of
samples measured for NP concentrations of 10–250 ng/
mL [19]. The wide variation of levels documented in
existing research coupled with our finding that 4NP is
present in nearly 1/3 of this pediatric population sug-
gests a need for further evaluation of this ubiquitous
chemical.
Analysis of the estrogen variables shows there were
no significant differences by age. As there were no
zero values for estrogen metabolites, all were above
the limit of detection. Upon analysis by gender, fe-
males have larger maximum, standard deviations and
slightly larger means for 2-OHE2 and 2-OHE1 + 2
(Table 2). 16a-OHE1 was the only estrogenic metabol-
ite significantly different (higher, in this case) in girls
than boys, with a p value of 0.013 from the Wilcoxon
test. Elevated levels of this metabolite are linked to in-
creased risk and worse prognosis for estrogen-sensitive
cancers and autoimmune conditions [30], though the
specific levels measured in this study are not directly
associated with known health risks. It is not known if girls
simply have relatively higher levels of 16a-OHE1 than
boys.
Since the data is skewed and non-normal, we use the
Spearman’s correlation coefficient (ρ) to assess the corre-
lations between estrogen markers and chemicals. Using
a test to assess whether ρ is zero or not [31], we found
that none of the correlations were statistically significant
at the 0.1 level after accounting for multiple testing.
There was a widely divergent single outlier identified
for most chemicals: the 22nd male had high values of tri-
closan, 21st male of 4NP and the 23rd male of MetP. The
23rd female had high values of 4NP and propylparaben,
and the 24th female of ethylparaben. It would be
interesting to explore the possibility of subpopulations
that are particularly at risk of higher exposures to these
chemicals and/or increased risk for health effects from
exposures. But with only 3 such subjects we are not able
to do this for our data. Therefore, this pilot study
suggests the need for additional research with a larger
population.
Limitations
A limitation of this study was the small sample size (50),
with only 5 boys and 5 girls in each age group. There is
an instance of an extremely large chemical outlier value.
This outlier greatly affected the correlation coefficient
between chemical concentrations and estrogen metabol-
ism markers. All the other data points showed no correl-
ation between the variables. Further investigation into
the measurement process would need to be done to
Table 2 Summary of estrogen metabolites
All subjects (N = 50) 25 Males 25 Females P values for
Wilcoxon test for
males v. females
ng/mg creatinine ng/mg creatinine ng/mg creatinine
Min Median IQR Max Min Median IQR Max Min Median IQR Max
2-16Ratio 2.50 17.45 92.05 1386.30 3.00 27.40 91.80 655.00 2.50 11.00 25.20 1386.30 0.14
4-OHE1 0.07 0.08 0.13 1.50 0.07 0.07 0.13 1.50 0.07 0.10 0.13 0.50 0.74
LOD = 0.067 ng/mL
2-OHE1 0.15 0.15 0.23 2.40 0.15 0.15 0.25 2.10 0.15 0.15 0.15 2.40 0.60
LOD = 0.150 ng/mL
2-OHE2 0.06 1.25 5.70 101.00 0.10 1.80 6.90 66.80 0.06 1.10 1.80 101.00 0.40
LOD = 0.065 ng/mL
2-OHE(1 + 2) 0.30 1.70 6.35 101.20 0.40 2.00 6.70 67.50 0.30 1.70 2.30 101.20 0.72
16a-OHE1 0.07 0.07 0.03 0.50 0.07 0.07 0.00 0.20 0.07 0.10 0.13 0.50 0.013
LOD = 0.073 ng/mL
2-OMeE1 0.10 0.10 0.10 2.10 0.10 0.10 0.10 2.10 0.10 0.10 0.00 0.40 0.37
LOD = 0.103 ng/mL
4-OMeE1 0.23 0.23 0.00 2.10 0.23 0.23 0.00 2.10 0.23 0.23 0.00 0.40 0.60
LOD = 0.230 ng/mL
Note: Full names of the abbreviated estrogen metabolites and ratio are in the List of Abbreviations
Ihde et al. BMC Endocrine Disorders  (2015) 15:83 Page 6 of 8
determine if the outlier value is spurious. It must be
noted that even if the value is not spurious, an inference
cannot be drawn based on one observation. The small
sample size may be a reason we are unable to determine
any correlation between chemical concentrations and
estrogen metabolism markers. Considering the lack of
statistically significant difference in estrogen metabolism
between boys and girls in this study, it may be that pre-
pubertal children do not demonstrate this correlation
while post-pubertal adolescents and adults do, perhaps
as a function of the low estrogen values in pre-pubertal
children. Additionally, after pubertal onset, the asso-
ciations may be sexually dimorphic, as has been
observed in some pediatric cohorts [19].
Further research evaluating larger samples sizes of
pre- and post-pubertal subjects would be of value, given
the presence of eight or more hormonally disruptive
chemicals in nearly three-fourths of subjects.
Conclusions
Endocrine disrupting environmental chemicals were de-
tected in all children in the study, and nearly three-
quarters of subjects had detectible levels of eight or more
chemicals. Nearly 1/3 of subjects had measurable levels of
4NP in their urine, a novel finding, suggesting a need for
more research regarding the presence and impact of this
chemical. After the removal of outliers, no associations
were found between the urine levels of chemicals tested
and estrogen metabolites. However, the presence of mul-
tiple chemicals in a majority of children’s urine coupled
with increasing prevalence of pediatric hormonal disor-
ders warrants further research to elucidate potential causal
mechanisms in pre- and post-pubertal children.
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